Research
Title : | Therapeutic outcomes with second-line drug exposures in a cohort of South African and Indian patients with drug resistant TB: A pharmacokineticpharmacodynamic assessment |
Area of research : | Life Sciences & Biotechnology, Medical Sciences |
Focus area : | Drug resistant TB |
Principal Investigator : | Dr. Tester F Ashavaid, Director, P.D. Hinduja National Hospital & Medical Research Centre, Mumbai |
Timeline Start Year : | 2018 |
Timeline End Year : | 2021 |
Contact info : | dr tashavaid @hindujahospital.com |
Details
Total Budget (INR): | 1,79,91,840 |
Organizations involved
Implementing Agency : | P.D. Hinduja National Hospital & Medical Research Centre, Mumbai Funding Agency :Department of Biotechnology (DBT), Government of Inida | |